We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > baloxavir marboxil

News List

A Better Anti-Influenza Solution: Roche’s Blockbuster New Drug Applied for Marketing in China PharmaSources/Xiaoyaowan
June 24, 2020
According to the website of the CDE on June 10, the marketing applications of Roche for its new drug Baloxavir Marboxil Tablets in China have been accepted by the CDE.
Roche unveils PhIII data for flu drug pharmatimes
October 11, 2018
Roche has unveiled late-stage data showing that its experimental antivrial drug baloxavir marboxil hit efficacy and safety targets in patients with flu.
FDA Grants Priority Review to Baloxavir Marboxil for Influenza americanpharmaceuticalreview
June 27, 2018
Genentech announced the U.S. Food and Drug Administration (FDA) has accepted a New Drug Application (NDA) and granted Priority Review for baloxavir marboxil as a single-dose